AccessibilityHelpAbout Us
BICO Group logo

BICO Group(OTC) CLLKF

Market Cap$159.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-84%
5 Year-96%
1 Year-12%
1 Month+48%
$2.26
+0.00%
+0.00Today
BICO Group last closing stock price
MetricPriceDate
Last closeUSD 2.262026-09-10
BICO Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.11%USD 2.072026-08-27
1 month+47.61%USD 1.532026-07-29
3 month+28.18%USD 1.762026-06-12
Year to date-8.19%USD 2.462025-12-31
1 year-11.6%USD 2.562025-08-28
3 year-37.78%USD 3.632023-09-11
5 year-96.24%USD 60.002021-09-10
Since inception-84.07%USD 14.182017-11-15

BICO Group Financials at a Glance

Market Cap

$159.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.50B

Net Income (TTM)

-SEK 834.23M

EPS (TTM)

-$1.26

P/E Ratio

-1.79

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$2.26

Volume

60

Open

$2.26

Previous Close

$2.26

Daily Range

$2.26 - $2.26

52-Week Range

$1.52 - $2.73

Estimated Earnings Date

Nov 11, 2026

CLLKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BICO Group

BICO Group AB (publ) is a global bio-convergence enterprise, operating in North America, Europe, Asia, and other international markets. The company focuses on advanced laboratory solutions and bioautomation, catering primarily to the medical, pharmaceutical, and cosmetic sectors.

Products and Services
  • 3D bioprinters and hybrid microscopy systems
  • Precision dispensing and biosensor technology
  • 3D cell culture and digital pathology services
Growth Outlook
  • Revenue of 333 million SEK in Q2 2026, showing consistent demand
  • Gross profit margin improved to 46.8% in Q2 2026
  • Strong cash position with 622 million SEK in cash and equivalents
Financial Highlights
  • Net income of -36.9 million SEK in Q2 2026, reflecting ongoing investments
  • Operating income margin at -9.8% in Q2 2026, indicating operational challenges
  • Current ratio of 2.42, showcasing strong liquidity position
BICO Group AB (publ) is positioned in a rapidly evolving sector, focusing on innovative solutions that address the needs of various industries. The company's diverse product offerings, including advanced laboratory equipment and bioautomation technologies, cater to a wide range of clients, enhancing its market presence. Recent financial performance indicates a commitment to growth, despite facing operational challenges. The improvement in gross profit margin and a solid cash position suggest potential for future profitability. Investors may find BICO Group's strategic focus on bio-convergence and its robust product portfolio appealing as the company navigates the complexities of the healthcare landscape.
AI Generated • Aug 24, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

602

CEO

Maria Ada Eufemia Forss, MBA

Website

bico.com

Headquarters

Gothenburg, VG 412 63, SE

CLLKF Financials

Key Financial Metrics (TTM)

Gross Margin

45.61%

Operating Margin

-11.37%

Net Income Margin

-55.79%

Return on Equity

-49.84%

Return on Capital

-7.75%

Return on Assets

-29.64%

Earnings Yield

-55.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$159.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.57M

Volume

60

Avg. Volume

2.77K

Financials (TTM)

Gross Profit

SEK 683.05M

Operating Income

-SEK 170.37M

EBITDA

-SEK 1.00B

Operating Cash Flow

SEK 12.15M

Capital Expenditure

-SEK 17.15M

Free Cash Flow

-SEK 5.00M

Cash & ST Invst.

SEK 622.23M

Total Debt

SEK 680.82M

BICO Group Performance Analysis

BICO Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 209,567,42543.1%
20232023-12-31SEK 189,375,529-9.6%
20242024-12-31SEK 163,363,659-13.7%
20252025-12-31SEK 152,658,541-6.6%
BICO Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3018.5%
Q42025-12-3117.2%
Q12026-03-31-26.7%
Q22026-06-301.0%
BICO Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -1.21180.7%
20232023-12-31SEK -1.5729.1%
20242024-12-31SEK -0.01-99.5%
20252025-12-31SEK -1.5721159.5%
BICO Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3096.3%
Q42025-12-3190.3%
Q12026-03-31-121.4%
Q22026-06-3072.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 333.22M

+2.8%

Gross Profit

SEK 156.05M

+9.6%

Gross Margin

46.83%

N/A

Market Cap

$159.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$229.34K

N/A

Employees

695

N/A

Net Income

-SEK 36.88M

+80.0%

EBITDA

SEK 12.99M

+129.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 622.23M

+829.6%

Total Debt

SEK 680.82M

-51.6%

Accounts Receivable

SEK 279.59M

+783.2%

Inventory

SEK 205.92M

-11.8%

Long Term Debt

SEK 621.54M

+150.2%

Short Term Debt

SEK 59.29M

-94.9%

Return on Assets

-29.64%

N/A

Return on Invested Capital

-7.30%

N/A

Free Cash Flow

-SEK 61.17M

-79.9%

Operating Cash Flow

-SEK 55.52M

-96.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MLLCFMolecular Partners AG
$4.01+0.00%
CYBQFCYBERDYNE Inc.
$1.31+0.00%
NDTPNDT Pharmaceuticals Inc.
$0.42+0.00%
YOURFYourWay Cannabis Brands Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About CLLKF

What is the current price of BICO Group?

BICO Group is trading at $2.26 per share.

What is the 52-week range for BICO Group?

Over the past 52 weeks, BICO Group has traded between $1.52 and $2.73.

How much debt does BICO Group have?

As of the most recent reporting period, BICO Group reported total debt of SEK 70.95M.

How much cash does BICO Group have on hand?

BICO Group reported SEK 64.85M in cash and cash equivalents in its most recent financial results.

What is BICO Group’s dividend yield?

BICO Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services